A group of 8 senators have written a letter to the Pharmaceutical Research and Manufacturers of America (PhRMA) asking them what solutions they have for lowering drug prices; the number of measles cases in the United States has surpassed 1000; Kirsten Gillibrand has a plan to legalize marijuana and expunge all nonviolent criminal charges associated with it.
Seeking cooperation from drug companies as the United States continues to search for ways to address drug costs, senators have sent a letter to the Pharmaceutical Research and Manufacturers of America (PhRMA) asking them what solutions they have for increasing transparency and lowering prices, reported The Hill. Led by Senator Rick Scott, R-Florida, the group of 8 Republican senators asked the trade association what specific plans they have to address price disparities in the international market and asked if they are willing to work with the group to find real solutions.Six months into the year, the United States has recorded 1001 cases of the measles, marking the worst outbreak of the disease since 1992. According to The New York Times, there have been 61 new cases of the measles since May 27. The announcement of these new cases came as federal health officials issued a new plea for parents to vaccine their children. HHS Secretary Alex Azar re-emphasized that vaccines are a safe and highly effective public health tool that can prevent measles and end the current outbreak.Democratic presidential hopeful Kirsten Gillibrand has announced a plan to legalize marijuana and expunge all nonviolent criminal charges associated with it. According to the Associated Press, Gillibrand said she wants to ensure medical marijuana is covered by private health insurance and by Medicare, Medicaid, and the Department of Veterans Affairs. By working with Congress to decriminalize recreational marijuana use and tax nonprescription products, she said that she wants to use the proceeds to support job training and other programs for communities “disproportionately harmed by marijuana laws.”
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More